In SAM et al. v. Kennedy (1:26-cv-01081), the Court Weighs Whether CMS Overstepped Its Authority by allowing Hemp, Marijuana Cannabinoid Access Without FDA Approval. Duane Boise, CEO of MMJ ...
The Centers for Medicare & Medicaid Services will provide eligible Medicare beneficiaries monthly access to certain GLP-1 medications for $50 per month beginning July 1, 2026, through December 31, ...
The BALANCE program was intended to cover weight-loss drugs for Medicaid beneficiaries, but is delayed. A new solution with some downsides takes its place.
On April 23, 2026, the Food and Drug Administration (FDA) and Centers for Medicare & Medicaid Services (CMS) jointly announced the ...
Verywell Health on MSN
Medicare program to offer GLP-1 drugs for $50 per month starting in July
Fact checked by Jennifer Klump Key Takeaways The Medicare GLP-1 Bridge program will cover weight loss drugs for a $50 monthly ...
Leading Republicans are looking toward the Government Accountability Office (GAO) to ensure CMS' new premium stabilization demonstration program is legal and in the best interest of seniors. In a ...
Should Medicare change the default option for new beneficiaries to Medicare Advantage or an ACO, this could backfire as costs ...
CMS has published a list of 202 measures under consideration for use in hospitals and other Medicare public reporting and payment programs. In publishing the list, CMS will be able to gain input on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results